176 related articles for article (PubMed ID: 35592243)
1. Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology.
Zhao D; Zhang X; Tang Y; Guo P; Ai R; Hou M; Wang Y; Yuan X; Cui L; Zhang Y; Zhao S; Li W; Wang Y; Sun X; Liu L; Dong S; Li L; Zhao W; Nan Y
J Hepatocell Carcinoma; 2022; 9():389-403. PubMed ID: 35592243
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of plasma AGRN as a novel diagnostic biomarker of hepatitis B Virus-related chronic hepatitis and liver fibrosis/cirrhosis.
Ai R; Li L; Yuan X; Zhao D; Miao T; Guan W; Dong S; Dong C; Dou Y; Hou M; Nan Y
Histol Histopathol; 2023 Dec; ():18695. PubMed ID: 38197199
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential plasma markers for hepatitis B virus-related chronic hepatitis and liver fibrosis/cirrhosis.
Zhao D; Yu S; Guo P; Zhang X; Tang Y; Dong C; Zhao S; Li L; Al-Dhamin Z; Ai R; Xue N; Dong S; Nan Y
J Med Virol; 2022 Aug; 94(8):3900-3910. PubMed ID: 35420168
[TBL] [Abstract][Full Text] [Related]
4. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
Song T; Wang L; Xin R; Zhang L; Tian Y
J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
[TBL] [Abstract][Full Text] [Related]
7.
Song J; Liu L; Wang Z; Xie D; Azami NLB; Lu L; Huang Y; Ye W; Zhang Q; Sun M
Heliyon; 2024 Apr; 10(7):e28329. PubMed ID: 38596115
[TBL] [Abstract][Full Text] [Related]
8. Serum Levels of ITGBL1 as an Early Diagnostic Biomarker for Hepatocellular Carcinoma with Hepatitis B Virus Infection.
Ye F; Huang W; Xue Y; Tang E; Wang M; Shi F; Wei D; Han Y; Chen P; Zhang X; Yu D
J Hepatocell Carcinoma; 2021; 8():285-300. PubMed ID: 33948441
[TBL] [Abstract][Full Text] [Related]
9. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
Wang X; Li MM; Niu Y; Zhang X; Yin JB; Zhao CJ; Wang RT
Dis Markers; 2019; 2019():5945721. PubMed ID: 31485278
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α-induced protein 8-like 2 mRNA in peripheral blood mononuclear cells is associated with the disease progression of chronic hepatitis B virus infection.
Liu Y; Jin J; Ji J; Gao XM; Fan YC
Virol J; 2019 Oct; 16(1):120. PubMed ID: 31661000
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection.
Du WJ; Zhen JH; Zeng ZQ; Zheng ZM; Xu Y; Qin LY; Chen SJ
Diagn Pathol; 2013 Feb; 8():40. PubMed ID: 23448394
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
Li L; Gu X; Fang M; Ji J; Yi C; Gao C
Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
[TBL] [Abstract][Full Text] [Related]
13. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
14. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma.
Zhou J; Yang W; Zhang S; He X; Lin J; Zhou T; Li Y; Wang G; Chen J
Cancer Manag Res; 2019; 11():7159-7169. PubMed ID: 31534368
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
[TBL] [Abstract][Full Text] [Related]
18. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
[TBL] [Abstract][Full Text] [Related]
19. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
20. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
